The global transdermal drug delivery system market is estimated to register a CAGR of 8.91% over the forecast period of 2017-2023. Transdermal drug delivery involves delivering the drug the medications in systemic circulation through skin at a controlled rate, thereby, maintaining effective plasma level concentration of the drug in body over prolong period of time. The drugs are usually applied in the form of ointment, patches or plaster which is then absorbed into the systemic circulation. Skin age, condition, physicochemical factors and environmental factors are some factors that are to be considered while delivering drug through this route. The drug delivery is non-invasive and bypass first pass metabolism, thus, increasing the bioavailability of the drug. The rise in the market is attributed to the rising adoption of the TDDS due to the various advantages offered by TDDS such as prolonged therapeutic effect, reduced side-effects, improved bioavailability, better patient compliance and easy termination of drug therapy. However, inability of the skin to absorb large range of medications will restrain the market during the forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global transdermal drug delivery system market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global transdermal drug delivery system market.
Major industry players profiled as part of the report are 3M, Zosano Pharma Corporation, Tesa Labtec GmbH and Tapemark among others.
Segmentation
By Type
Patches
Gels and Ointments
By Application
Neurologic Conditions
Pain Management
Nicotine Cessation
Cardiovascular
Others
By End-Users
Hospitals and Clinics
Surgical Centers
Home Care Settings
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
Key questions answered by the report
What will be the global transdermal drug delivery system market size from 2018 to 2023?
How are the major drivers and restraints affecting the global transdermal drug delivery system market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
qKey strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth